Molecules (Dec 2024)

Mapping Thrombosis Serum Markers by <sup>1</sup>H-NMR Allied with Machine Learning Tools

  • Lucas G. Martins,
  • Bruna M. Manzini,
  • Silmara Montalvão,
  • Millene A. Honorato,
  • Marina P. Colella,
  • Gabriela G. Y. Hayakawa,
  • Erich V. de Paula,
  • Fernanda A. Orsi,
  • Erik S. Braga,
  • Nataša Avramović,
  • Folurunsho Bright Omage,
  • Ljubica Tasic,
  • Joyce M. Annichino-Bizzacchi

DOI
https://doi.org/10.3390/molecules29245895
Journal volume & issue
Vol. 29, no. 24
p. 5895

Abstract

Read online

Machine learning and artificial intelligence tools were used to investigate the discriminatory potential of blood serum metabolites for thromboembolism and antiphospholipid syndrome (APS). 1H-NMR-based metabonomics data of the serum samples of patients with arterial or venous thromboembolism (VTE) without APS (n = 32), thrombotic primary APS patients (APS, n = 32), and healthy controls (HCs) (n = 32) were investigated. Unique metabolic profiles between VTE and HCs, APS and HCs, and between VTE and triple-positive APS groups were indicative of the significant alterations in the metabolic pathways of glycolysis, the TCA cycle, lipid metabolism, and branched-chain amino acid (BCAA) metabolism, and pointed to the complex pathogenesis mechanisms of APS and VTE. Histidine, 3-hydroxybutyrate, and threonine were shown to be the top three metabolites with the most substantial impact on model predictions, suggesting that these metabolites play a pivotal role in distinguishing among APS, VTE, and HCs. These metabolites might be potential biomarkers to differentiate APS and VTE patients.

Keywords